Skip to main content
Erschienen in: Supportive Care in Cancer 9/2012

01.09.2012 | Original Article

Returning to work after treatment for haematological cancer: findings from Australia

verfasst von: Pam D. McGrath, Barbara Hartigan, Hamish Holewa, Maryanne Skarparis

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Despite the personal and economic importance of the issue of returning to work after cancer treatment, there are major limitations in the research literature on the topic. Indeed, in relation to the focus of the present article, the experience of return to work for Australian haematology patients, there is little research available.

Methods

The return-to-work findings are a sub-set from a study examining survivorship issues conducted through in-depth, qualitative interviews with a state-wide sample (n = 50) of individuals who were at least 1 year post-treatment for haematological malignancy.

Results

There were three groups identified in relation to employment: (1) those who were retired and work was not an issue, (2) those who had successfully re-entered the workforce and (3) those who wanted to work but were finding the process of return-to-work difficult. It is the third group that is the major focus for this paper.

Conclusions

The clear indications are that group 3 requires assistance with return-to-work and were vulnerable to a range of psychosocial distress caused by inability to return to employment. Supportive care strategies to assist return to employment are provided.
Relevance of manuscript to inform research, policies and/or programs
Current improvements in cancer treatments have not only increased the number of cancer survivors but also peoples’ ability to work during and following treatment. Maximising opportunities for cancer patients to return to work is a significant concern not only for individuals and employers but also economically for society. The findings reported in this article explored the individual story of a range of individuals with haematological malignancies in relation to their desire and efforts to return to work. Importantly, the findings not only provide insights on the work re-entry challenges faced by such individuals but also posit supportive care service delivery solutions to assist those who are vulnerable and frustrated in their efforts to find employment.
Literatur
1.
Zurück zum Zitat Amir Z, Wynn P, Chan F, Strauser D, Whitaker S, Luker K (2010) Return to work after cancer in the UK: attitudes and experiences of line managers. J Occup Rehabil 20(4):435–442PubMedCrossRef Amir Z, Wynn P, Chan F, Strauser D, Whitaker S, Luker K (2010) Return to work after cancer in the UK: attitudes and experiences of line managers. J Occup Rehabil 20(4):435–442PubMedCrossRef
2.
Zurück zum Zitat Mahar KK, Brintzenhofe K, Shields JJ (2008) The impact of changes in employment status on psychosocial well-being: a study of breast cancer survivors. J Psychosoc Oncol 26(3):1–17PubMedCrossRef Mahar KK, Brintzenhofe K, Shields JJ (2008) The impact of changes in employment status on psychosocial well-being: a study of breast cancer survivors. J Psychosoc Oncol 26(3):1–17PubMedCrossRef
3.
Zurück zum Zitat Pryce J, Munir F, Haslam C (2007) Cancer survivorship and work: symptoms, supervisor response, co-worker disclosure and work adjustment. J Occup Rehabil 17(1):83–92PubMedCrossRef Pryce J, Munir F, Haslam C (2007) Cancer survivorship and work: symptoms, supervisor response, co-worker disclosure and work adjustment. J Occup Rehabil 17(1):83–92PubMedCrossRef
4.
Zurück zum Zitat Taskila T, Lindbohm ML (2007) Factors affecting cancer survivors’ employment and work ability. Acta Oncol 46(4):446–451PubMedCrossRef Taskila T, Lindbohm ML (2007) Factors affecting cancer survivors’ employment and work ability. Acta Oncol 46(4):446–451PubMedCrossRef
5.
Zurück zum Zitat Rasmussen DM, Elverdam B (2008) The meaning of work and working life after cancer: an interview study. Psychooncology 17(12):1232–1238PubMedCrossRef Rasmussen DM, Elverdam B (2008) The meaning of work and working life after cancer: an interview study. Psychooncology 17(12):1232–1238PubMedCrossRef
6.
Zurück zum Zitat Short PF, Vasey JJ, Belue R (2008) Work disability associated with cancer survivorship and other chronic conditions. Psychooncology 17(1):91–97PubMedCrossRef Short PF, Vasey JJ, Belue R (2008) Work disability associated with cancer survivorship and other chronic conditions. Psychooncology 17(1):91–97PubMedCrossRef
7.
Zurück zum Zitat Quinlan E, Thomas-MacLean R, Hack T, Kwan W, Miedema B, Tatemichi S, Towers A, Tilley A (2009) The impact of breast cancer among Canadian women: disability and productivity. Work 34(3):285–296PubMed Quinlan E, Thomas-MacLean R, Hack T, Kwan W, Miedema B, Tatemichi S, Towers A, Tilley A (2009) The impact of breast cancer among Canadian women: disability and productivity. Work 34(3):285–296PubMed
8.
Zurück zum Zitat Park JH, Park JH, Kim SG (2009) Effect of cancer diagnosis on patient employment status: a nationwide longitudinal study in Korea. Psychooncology 18(7):691–699PubMedCrossRef Park JH, Park JH, Kim SG (2009) Effect of cancer diagnosis on patient employment status: a nationwide longitudinal study in Korea. Psychooncology 18(7):691–699PubMedCrossRef
9.
Zurück zum Zitat Fitschi L, Driscoll T (2006) Cancer due to occupation in Australia. Aust N Z J Public Health 30(3):213–219CrossRef Fitschi L, Driscoll T (2006) Cancer due to occupation in Australia. Aust N Z J Public Health 30(3):213–219CrossRef
10.
Zurück zum Zitat Gordon L, Lynch BM, Newman B (2008) Transitions in work participation after a diagnosis of colorectal cancer. Aust N Z J Public Health 32(6):569–574PubMedCrossRef Gordon L, Lynch BM, Newman B (2008) Transitions in work participation after a diagnosis of colorectal cancer. Aust N Z J Public Health 32(6):569–574PubMedCrossRef
11.
Zurück zum Zitat Cheung MC, Imrie KR, Friedlich J, Buckstein R, Lathia N, Mittmann N (2009) The impact of follicular (FL) and other indolent non-Hodgkin’s lymphomas (NHL) on work productivity—a preliminary analysis. Psychooncology 18(5):554–559PubMedCrossRef Cheung MC, Imrie KR, Friedlich J, Buckstein R, Lathia N, Mittmann N (2009) The impact of follicular (FL) and other indolent non-Hodgkin’s lymphomas (NHL) on work productivity—a preliminary analysis. Psychooncology 18(5):554–559PubMedCrossRef
12.
Zurück zum Zitat Sanchez KM, Richardson JL, Mason HRC (2004) The return to work experiences of colorectal cancer survivors. AAOHN J 52(12):500–510PubMed Sanchez KM, Richardson JL, Mason HRC (2004) The return to work experiences of colorectal cancer survivors. AAOHN J 52(12):500–510PubMed
13.
Zurück zum Zitat Yarker J, Munir F, Bains M, Kalawsky K, Haslam C (2010) The role of communication and support in return to work following cancer-related absence. Psychooncology 19(10):1078–1085PubMed Yarker J, Munir F, Bains M, Kalawsky K, Haslam C (2010) The role of communication and support in return to work following cancer-related absence. Psychooncology 19(10):1078–1085PubMed
14.
Zurück zum Zitat Tamminga SJ, de Boer AG, Verbeek JH, Frings-Dresen MH (2010) Return-to-work interventions integrated into cancer care: a systematic review. Occup Environ Med 67(9):639–648PubMedCrossRef Tamminga SJ, de Boer AG, Verbeek JH, Frings-Dresen MH (2010) Return-to-work interventions integrated into cancer care: a systematic review. Occup Environ Med 67(9):639–648PubMedCrossRef
15.
Zurück zum Zitat McGrath P, Hartigan B, Holewa H, Skaparis M (2011) ‘Chemo Brain’: research findings indicate need for caution. AJC 10(3):33–41 McGrath P, Hartigan B, Holewa H, Skaparis M (2011) ‘Chemo Brain’: research findings indicate need for caution. AJC 10(3):33–41
16.
Zurück zum Zitat Short PF, Vargo MM (2006) Responding to employment concerns of cancer survivors. J Clin Oncol 24(32):5138–5141PubMedCrossRef Short PF, Vargo MM (2006) Responding to employment concerns of cancer survivors. J Clin Oncol 24(32):5138–5141PubMedCrossRef
17.
Zurück zum Zitat Australian Institute of Health and Welfare (AIHW) (2010). Cancer in Australia 2010: an overview. Cancer series no. 60. Cat. no. CAN 56. Canberra: AIHW Australian Institute of Health and Welfare (AIHW) (2010). Cancer in Australia 2010: an overview. Cancer series no. 60. Cat. no. CAN 56. Canberra: AIHW
18.
Zurück zum Zitat Amir Z, Neary D, Luker K (2008) Cancer survivors’ views of work 3 years post diagnosis: a UK perspective. Eur J Oncol Nurs 12(3):190–197PubMedCrossRef Amir Z, Neary D, Luker K (2008) Cancer survivors’ views of work 3 years post diagnosis: a UK perspective. Eur J Oncol Nurs 12(3):190–197PubMedCrossRef
19.
Zurück zum Zitat Palmadottir G (2010) The role of occupational participation and environment among Icelandic women with breast cancer: a qualitative study. Scand J Occup Ther 17(4):299–307PubMedCrossRef Palmadottir G (2010) The role of occupational participation and environment among Icelandic women with breast cancer: a qualitative study. Scand J Occup Ther 17(4):299–307PubMedCrossRef
20.
Zurück zum Zitat Park JH, Park JH, Kim SG, Lee KS, Hahm MI (2010) Changes in employment status and experience of discrimination among cancer patients: findings from a nationwide survey in Korea. Psychooncology 19(12):1303–1312PubMedCrossRef Park JH, Park JH, Kim SG, Lee KS, Hahm MI (2010) Changes in employment status and experience of discrimination among cancer patients: findings from a nationwide survey in Korea. Psychooncology 19(12):1303–1312PubMedCrossRef
Metadaten
Titel
Returning to work after treatment for haematological cancer: findings from Australia
verfasst von
Pam D. McGrath
Barbara Hartigan
Hamish Holewa
Maryanne Skarparis
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1298-2

Weitere Artikel der Ausgabe 9/2012

Supportive Care in Cancer 9/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.